Antipsychotics at doses >75 mg/day are associated with an increased risk for tardive dyskinesia (TD), according to a study ...

HealthDay News — Antipsychotics at doses >75 mg ... (TD), according to a study recently published in the Journal of Clinical Psychopharmacology. Maki Gouda, from the Mitsubishi Tanabe Pharma ...

Significantly increased risk for tardive dyskinesia seen with doses >75 mg/day at last prescription and as maximum dose ...

Researchers from the National Healthcare Group (NHG)'s Institute of Mental Health (IMH) and Agency for Science, Technology ...

FRIDAY, Jan. 17, 2025 (HealthDay News) -- Antipsychotics at doses >75 mg/day are associated with an increased risk for tardive dyskinesia (TD), according to a study recently published in the Journal ...

Examining the difference between the terms "response" and "recovery" reflects the enormous difference in the worlds of scientific literature and the clinical practice of psychopharmacology.

Risperidone was marketed at too high a dose for the same reason: the clinical trials were designed ... for extrapyramidal symptoms (EPS) of antipsychotics, trazodone or sedative/hypnotics for ...

Peptide antigen-associated IgG levels were significantly lower in drug-naïve patients with first episode psychosis compared to control individuals.